Antigens main page header.jpg

Antigens

bbi-reagents-antigens-icon.svg

World class Antigens from BBI

BBI Solutions is the world’s primary manufacturer of high quality native human antigens, to a variety of disease states. Our native antigens are purified from human plasma and tissues which are all processed at our HTA registered site in the UK. Perfect to be used in antibody detection assays or used as a positive control in a number of different immunoassays, our wide range of native antigens are trusted by quality control testers and product developers worldwide for their high specificity and sensitivity. BBI Solutions develop and manufacture a range of recombinant human antigens in our modern, purpose built laboratories, with a focus on E. coli and Pichia expression systems.

The BBI Difference

Choice & Flexibility

Choice & Flexibility

Our core competencies include a comprehensive suite of reagents with custom development options, lateral flow development, diagnostic manufacturing services and smartphone reader technologies.

Quality System Certification

Quality System Certification

Each site follows strict Quality Control and product release protocols, which coupled with effective Quality Assurance processes ensure our products meet stringent product quality, safety and customer requirements.

Innovation

Innovation

Innovation is at the heart of our operations. The extensive breadth and depth of our products and services portfolio is testimony to the ongoing investment in our people and facilities.

Experience & Trust

Experience & Trust

BBI Solutions has been serving the global diagnostics industry for over 50 years and is the world’s largest independent producer of immuno-diagnostics reagents.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox